RecruitingPhase IIIEN originalPancreatic cancer

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Potwierdzony diagnozą raka trzustki (histologicznie lub przez cytologię) - diagnoza w ciągu ostatnich 8 tygodni
  • Zaawansowany, nieooperacyjny nowotwór trzustki potwierdony badaniem CT lub MRI
  • Wiek co najmniej 18 lat
  • Ogólny stan zdrowia pozwalający na chemioterapię (ECOG 0-1)
  • Prawidłowe wyniki badań krwi: wystarczająca liczba białych krwinek, płytek krwi i hemoglobiny
  • Prawidłowa funkcja nerek (kreatynina w normie lub oczyszczanie ≥50 mL/min)
  • Prawidłowa funkcja wątroby (enzymy AST/ALT i bilirubina w normie lub nieznacznie podwyższone)

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 24, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (42)

VA Loma Linda Healthcare System

Loma Linda, United States

Sutter Cancer Center Sacramento

Sacramento, United States

Rocky Mountain Cancer Centers

Denver, United States

Comprehensive Cancer Care and Research Institute of Colorado, CCCRIC

Englewood, United States

Sibley Memorial Hospital - a member of Johns Hopkins medicine

Washington D.C., United States

Georgetown University

Washington D.C., United States

21st Century Oncology

Fort Myers, United States

Miami Cancer Center

Miami, United States

Sarasota Memorial Health Care System

Sarasota, United States

Moffitt Cancer Center

Tampa, United States

ASCLEPES Research Centers

Weeki Wachee, United States

Piedmont-Columbus Regional - John B. Amos Cancer Center

Columbus, United States

University of Iowa Hospitals and Clinics - Holden Comprehensive Cancer Center

Iowa City, United States

Ochsner Clinic Foundation

New Orleans, United States

LSU Health Shreveport

Shreveport, United States

Medstar Franklin Square

Baltimore, United States

University of Nebraska Medical Center

Omaha, United States

Dartmouth-Hitchcock Medical Center

Lebanon, United States

MD Anderson Cancer Center at Cooper Hospital

Camden, United States

Atlantic Health System - Morristown Medical Center

Morristown, United States

Albany Stratton VA Medical Center

Albany, United States

Feinstein Institutes for Medical Research - Northwell Health

Manhasset, United States

Columbia University Medical Center

New York, United States

Montefiore Hospital

The Bronx, United States

Levine Cancer Institute - Atrium Health

Charlotte, United States

East Carolina University

Greenville, United States

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, United States

Oklahoma University - Stephenson Cancer Center

Oklahoma City, United States

Oregon Health & Science University

Portland, United States

University of Pittsburgh Medical Center

Pittsburgh, United States

Medical University of South Carolina - Hollings Cancer Center

Charleston, United States

Prisma Health (formerly Greenville Health System)

Greenville, United States

Sarah Cannon Research Institute

Nashville, United States

University of Texas Southwestern Medical Center

Dallas, United States

VA Puget Sound Health Care System

Seattle, United States

West Virginia University Medicine

Morgantown, United States

AZ Sint-Lucas

Bruges, Belgium

UZ Antwerp

Edegem, Belgium

AZ Maria Middelares

Ghent, Belgium

UZ Gent

Ghent, Belgium

Jolimont Hospital

La Louvière, Belgium

AZ Delta

Roeselare, Belgium

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/25/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.